Arteriosclerosis, Vol 10, 325-335, Copyright © 1990 by American Heart Association

ARTICLES

Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein

W Palinski, S Yla-Herttuala, ME Rosenfeld, SW Butler, SA Socher, S Parthasarathy, LK Curtiss and JL Witztum
Department of Medicine, University of California-San Diego, La Jolla 92093.

Increasing evidence indicates that low density lipoprotein (LDL) has to be modified to induce foam cell formation. One such modification, oxidation of LDL, generates a number of highly reactive short chain- length aldehydic fragments of oxidized fatty acids capable of conjugating with lysine residues of apoprotein B. By immunizing animals with homologous malondialdehyde-modified LDL (MDA-LDL), 4- hydroxynonenal-LDL (4-HNE-LDL), and Cu+(+)-oxidized LDL, we developed polyvalent and monoclonal antibodies against three epitopes found in oxidatively modified LDL. The present article characterizes an antiserum and monoclonal antibody (MAL-2 and MDA2, respectively) specific for MDA-lysine, and an antiserum and monoclonal antibody (HNE- 6 and NA59, respectively) specific for 4-HNE-lysine. In addition, a monoclonal antibody (OLF4-3C10) was developed against an as yet undefined epitope generated during Cu++ oxidation of LDL. With these antibodies, we demonstrated that MDA-lysine and 4-HNE-lysine adducts develop on apo-lipoprotein B during copper-induced oxidation of LDL in vitro. The application of these antibodies for immunocytochemical demonstration of oxidized lipoproteins in atherosclerotic lesions of progressive severity is described in the companion article. These antibodies should prove useful in studying the role of oxidatively modified lipoproteins as well as other oxidatively modified proteins in atherogenesis.

This article has been cited by other articles:

				D. Mannheim, J. Herrmann, D. Versari, M. Gossl, F. B. Meyer, J. P. McConnell, L. O. Lerman, and A. Lerman Enhanced Expression of Lp-PLA2 and Lysophosphatidylcholine in Symptomatic Carotid Atherosclerotic Plaques Stroke, May 1, 2008; 39(5): 1448 - 1455. [Abstract] [Full Text] [PDF]

				G. S. Ginsburg Regression of Atherosclerosis With Therapeutic Antibodies: Pipe Cleaner or Pipe Dream? J. Am. Coll. Cardiol., December 11, 2007; 50(24): 2319 - 2321. [Full Text] [PDF]

				T. Yamashita, S. Freigang, C. Eberle, J. Pattison, S. Gupta, C. Napoli, and W. Palinski Maternal Immunization Programs Postnatal Immune Responses and Reduces Atherosclerosis in Offspring Circ. Res., September 29, 2006; 99(7): E51 - E64. [Abstract] [Full Text] [PDF]

				G. N. Fredrikson, G. Berglund, R. Alm, J.-A. Nilsson, P. K. Shah, and J. Nilsson Identification of autoantibodies in human plasma recognizing an apoB-100 LDL receptor binding site peptide J. Lipid Res., September 1, 2006; 47(9): 2049 - 2054. [Abstract] [Full Text] [PDF]

				A. Tuominen, Y. I. Miller, L. F. Hansen, Y. A. Kesaniemi, J. L. Witztum, and S. Horkko A Natural Antibody to Oxidized Cardiolipin Binds to Oxidized Low-Density Lipoprotein, Apoptotic Cells, and Atherosclerotic Lesions Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2096 - 2102. [Abstract] [Full Text] [PDF]

				J. Nigro, N. Osman, A. M. Dart, and P. J. Little Insulin Resistance and Atherosclerosis Endocr. Rev., May 1, 2006; 27(3): 242 - 259. [Abstract] [Full Text] [PDF]

				M. J. Duryee, T. L. Freeman, M. S. Willis, C. D. Hunter, B. C. Hamilton III, H. Suzuki, D. J. Tuma, L. W. Klassen, and G. M. Thiele Scavenger Receptors on Sinusoidal Liver Endothelial Cells Are Involved in the Uptake of Aldehyde-Modified Proteins Mol. Pharmacol., November 1, 2005; 68(5): 1423 - 1430. [Abstract] [Full Text] [PDF]

				J. Tang, K. Kozaki, A. G. Farr, P. J. Martin, P. Lindahl, C. Betsholtz, and E. W. Raines The Absence of Platelet-Derived Growth Factor-B in Circulating Cells Promotes Immune and Inflammatory Responses in Atherosclerosis-Prone ApoE-/- Mice Am. J. Pathol., September 1, 2005; 167(3): 901 - 912. [Abstract] [Full Text] [PDF]

				C. J. Binder, P. X. Shaw, M.-K. Chang, A. Boullier, K. Hartvigsen, S. Horkko, Y. I. Miller, D. A. Woelkers, M. Corr, and J. L. Witztum Thematic review series: The Immune System and Atherogenesis. The role of natural antibodies in atherogenesis J. Lipid Res., July 1, 2005; 46(7): 1353 - 1363. [Abstract] [Full Text] [PDF]

				H. Arakawa, J.-Y. Qian, D. Baatar, K. Karasawa, Y. Asada, Y. Sasaguri, E. R. Miller, J. L. Witztum, and H. Ueno Local Expression of Platelet-Activating Factor-Acetylhydrolase Reduces Accumulation of Oxidized Lipoproteins and Inhibits Inflammation, Shear Stress-Induced Thrombosis, and Neointima Formation in Balloon-Injured Carotid Arteries in Nonhyperlipidemic Rabbits Circulation, June 21, 2005; 111(24): 3302 - 3309. [Abstract] [Full Text] [PDF]

				I. Goncalves, M.-L. M. Gronholdt, I. Soderberg, M. P.S. Ares, B. G. Nordestgaard, J. F. Bentzon, G. N. Fredrikson, and J. Nilsson Humoral Immune Response Against Defined Oxidized Low-Density Lipoprotein Antigens Reflects Structure and Disease Activity of Carotid Plaques Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1250 - 1255. [Abstract] [Full Text] [PDF]

				M. Torzewski, P. X. Shaw, K.-R. Han, B. Shortal, K. J. Lackner, J. L. Witztum, W. Palinski, and S. Tsimikas Reduced In Vivo Aortic Uptake of Radiolabeled Oxidation-Specific Antibodies Reflects Changes in Plaque Composition Consistent With Plaque Stabilization Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2307 - 2312. [Abstract] [Full Text] [PDF]

				K. S. Michelsen, T. M. Doherty, P. K. Shah, and M. Arditi TLR Signaling: An Emerging Bridge from Innate Immunity to Atherogenesis J. Immunol., November 15, 2004; 173(10): 5901 - 5907. [Abstract] [Full Text] [PDF]

				V. Ribas, J. L. Sanchez-Quesada, R. Anton, M. Camacho, J. Julve, J. C. Escola-Gil, L. Vila, J. Ordonez-Llanos, and F. Blanco-Vaca Human Apolipoprotein A-II Enrichment Displaces Paraoxonase From HDL and Impairs Its Antioxidant Properties: A New Mechanism Linking HDL Protein Composition and Antiatherogenic Potential Circ. Res., October 15, 2004; 95(8): 789 - 797. [Abstract] [Full Text] [PDF]

				G. Virella, S. R. Thorpe, N. L. Alderson, M. B. Derrick, C. Chassereau, J. M. Rhett, and M. F. Lopes-Virella Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies J. Lipid Res., October 1, 2004; 45(10): 1859 - 1867. [Abstract] [Full Text] [PDF]

				H. F. Poon, V. Calabrese, G. Scapagnini, and D. A. Butterfield Free Radicals: Key to Brain Aging and Heme Oxygenase as a Cellular Response to Oxidative Stress J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2004; 59(5): M478 - M493. [Abstract] [Full Text] [PDF]

				M.-L. Silaste, M. Rantala, G. Alfthan, A. Aro, J. L. Witztum, Y. A. Kesaniemi, and S. Horkko Changes in Dietary Fat Intake Alter Plasma Levels of Oxidized Low-Density Lipoprotein and Lipoprotein(a) Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 498 - 503. [Abstract] [Full Text]

				G. Virella and M. F. Lopes-Virella Lipoprotein Autoantibodies: Measurement and Significance Clin. Vaccine Immunol., July 1, 2003; 10(4): 499 - 505. [Full Text] [PDF]

				P. X. Shaw, C. S. Goodyear, M.-K. Chang, J. L. Witztum, and G. J. Silverman34 The Autoreactivity of Anti-Phosphorylcholine Antibodies for Atherosclerosis-Associated Neo-Antigens and Apoptotic Cells J. Immunol., June 15, 2003; 170(12): 6151 - 6157. [Abstract] [Full Text] [PDF]

				G. N. Fredrikson, B. Hedblad, G. Berglund, R. Alm, M. Ares, B. Cercek, K.-Y. Chyu, P. K. Shah, and J. Nilsson Identification of Immune Responses Against Aldehyde-Modified Peptide Sequences in ApoB Associated With Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., May 1, 2003; 23(5): 872 - 878. [Abstract] [Full Text] [PDF]

				G. N. Fredrikson, I. Soderberg, M. Lindholm, P. Dimayuga, K.-Y. Chyu, P. K. Shah, and J. Nilsson Inhibition of Atherosclerosis in ApoE-Null Mice by Immunization with ApoB-100 Peptide Sequences Arterioscler. Thromb. Vasc. Biol., May 1, 2003; 23(5): 879 - 884. [Abstract] [Full Text] [PDF]

				G. Virella, S. R. Thorpe, N. L. Alderson, E. M. Stephan, D. Atchley, F. Wagner, and M. F. Lopes-Virella Autoimmune response to advanced glycosylation end-products of human LDL J. Lipid Res., March 1, 2003; 44(3): 487 - 493. [Abstract] [Full Text] [PDF]

				M. Xia, W. H. Ling, J. Ma, D. D. Kitts, and J. Zawistowski Supplementation of Diets with the Black Rice Pigment Fraction Attenuates Atherosclerotic Plaque Formation in Apolipoprotein E Deficient Mice J. Nutr., March 1, 2003; 133(3): 744 - 751. [Abstract] [Full Text] [PDF]

				G. K. Hansson Vaccination Against Atherosclerosis: Science or Fiction? Circulation, September 24, 2002; 106(13): 1599 - 1601. [Full Text] [PDF]

				M. Aikawa, S. Sugiyama, C. C. Hill, S. J. Voglic, E. Rabkin, Y. Fukumoto, F. J. Schoen, J. L. Witztum, and P. Libby Lipid Lowering Reduces Oxidative Stress and Endothelial Cell Activation in Rabbit Atheroma Circulation, September 10, 2002; 106(11): 1390 - 1396. [Abstract] [Full Text] [PDF]

				L. J. Pinderski, M. P. Fischbein, G. Subbanagounder, M. C. Fishbein, N. Kubo, H. Cheroutre, L. K. Curtiss, J. A. Berliner, and W. A. Boisvert Overexpression of Interleukin-10 by Activated T Lymphocytes Inhibits Atherosclerosis in LDL Receptor-Deficient Mice by Altering Lymphocyte and Macrophage Phenotypes Circ. Res., May 31, 2002; 90(10): 1064 - 1071. [Abstract] [Full Text] [PDF]

				F. Bilora, V. Boccioletti, B. Girolami, E. Zanon, M. Armani, F. Petrobelli, and A. Girolami Are Antiphospholipid Antibodies an Independent Risk Factor for Atherosclerosis? Clinical and Applied Thrombosis/Hemostasis, April 1, 2002; 8(2): 103 - 113. [Abstract] [PDF]

				P. Friedman, S. Horkko, D. Steinberg, J. L. Witztum, and E. A. Dennis Correlation of Antiphospholipid Antibody Recognition with the Structure of Synthetic Oxidized Phospholipids. IMPORTANCE OF SCHIFF BASE FORMATION AND ALDOL CONDENSATION J. Biol. Chem., February 22, 2002; 277(9): 7010 - 7020. [Abstract] [Full Text] [PDF]

				G. Subbanagounder, J. W. Wong, H. Lee, K. F. Faull, E. Miller, J. L. Witztum, and J. A. Berliner Epoxyisoprostane and Epoxycyclopentenone Phospholipids Regulate Monocyte Chemotactic Protein-1 and Interleukin-8 Synthesis. FORMATION OF THESE OXIDIZED PHOSPHOLIPIDS IN RESPONSE TO INTERLEUKIN-1beta J. Biol. Chem., February 22, 2002; 277(9): 7271 - 7281. [Abstract] [Full Text] [PDF]

				G. K. Hansson Immune Mechanisms in Atherosclerosis Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 1876 - 1890. [Abstract] [Full Text] [PDF]

				J. H. Brasen, A. Kivela, K. Roser, T. T. Rissanen, M. Niemi, F. C. Luft, K. Donath, and S. Yla-Herttuala Angiogenesis, Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor-BB Expression, Iron Deposition, and Oxidation-Specific Epitopes in Stented Human Coronary Arteries Arterioscler. Thromb. Vasc. Biol., November 1, 2001; 21(11): 1720 - 1726. [Abstract] [Full Text] [PDF]

				E. Svenungsson, K. Jensen-Urstad, M. Heimburger, A. Silveira, A. Hamsten, U. de Faire, J. L. Witztum, and J. Frostegard Risk Factors for Cardiovascular Disease in Systemic Lupus Erythematosus Circulation, October 16, 2001; 104(16): 1887 - 1893. [Abstract] [Full Text] [PDF]

				P. X. Shaw, S. Horkko, S. Tsimikas, M.-K. Chang, W. Palinski, G. J. Silverman, P. P. Chen, and J. L. Witztum Human-Derived Anti-Oxidized LDL Autoantibody Blocks Uptake of Oxidized LDL by Macrophages and Localizes to Atherosclerotic Lesions In Vivo Arterioscler. Thromb. Vasc. Biol., August 1, 2001; 21(8): 1333 - 1339. [Abstract] [Full Text] [PDF]

				T. Inoue, T. Uchida, H. Kamishirado, K. Takayanagi, and S. Morooka Antibody against oxidized low density lipoprotein may predict progression or regression of atherosclerotic coronary artery disease J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1871 - 1876. [Abstract] [Full Text] [PDF]

				M. A. Ostos, M. Conconi, L. Vergnes, N. Baroukh, J. Ribalta, J. Girona, J.-M. Caillaud, A. Ochoa, and M. M. Zakin Antioxidative and Antiatherosclerotic Effects of Human Apolipoprotein A-IV in Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 1023 - 1028. [Abstract] [Full Text] [PDF]

				G Hayem, P Nicaise-Roland, E Palazzo, M de Bandt, F Tubach, M Weber, and O Meyer Anti-oxidized low-density-lipoprotein (OxLDL) antibodies in systemic lupus erythematosus with and without antiphospholipid syndrome Lupus, May 1, 2001; 10(5): 346 - 351. [Abstract] [PDF]

				P A Gordon, J George, M A Khamashta, D Harats, G Hughes, and Y Shoenfeld Atherosclerosis and autoimmunity Lupus, April 1, 2001; 10(4): 249 - 252. [Abstract] [PDF]

				W. F. Penny, O. Ben-Yehuda, K. Kuroe, J. Long, A. Bond, V. Bhargava, J. F. Peterson, M. McDaniel, J. Juliano, J. L. Witztum, et al. Improvement of coronary artery endothelial dysfunction with lipid-lowering therapy: heterogeneity of segmental response and correlation with plasma-oxidized low density lipoprotein J. Am. Coll. Cardiol., March 1, 2001; 37(3): 766 - 774. [Abstract] [Full Text] [PDF]

				T. Inoue, T. Uchida, H. Kamishirado, K. Takayanagi, T. Hayashi, and S. Morooka Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease J. Am. Coll. Cardiol., March 1, 2001; 37(3): 775 - 779. [Abstract] [Full Text] [PDF]

				S. Horkko, T. Olee, L. Mo, D. W. Branch, V. L. Woods Jr, W. Palinski, P. P. Chen, and J. L. Witztum Anticardiolipin Antibodies From Patients With the Antiphospholipid Antibody Syndrome Recognize Epitopes in Both {beta}2-Glycoprotein 1 and Oxidized Low-Density Lipoprotein Circulation, February 20, 2001; 103(7): 941 - 946. [Abstract] [Full Text] [PDF]

				D. Pratico, R. K. Tangirala, S. Horkko, J. L. Witztum, W. Palinski, and G. A. FitzGerald Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F2{alpha}-VI levels and the extent of atherosclerosis in ApoE-deficient mice: modulation by vitamin E Blood, January 15, 2001; 97(2): 459 - 464. [Abstract] [Full Text] [PDF]

				S. Tsimikas, W. Palinski, and J. L. Witztum Circulating Autoantibodies to Oxidized LDL Correlate With Arterial Accumulation and Depletion of Oxidized LDL in LDL Receptor-Deficient Mice Arterioscler. Thromb. Vasc. Biol., January 1, 2001; 21(1): 95 - 100. [Abstract] [Full Text] [PDF]

				J. Hulthe, L. Bokemark, and B. Fagerberg Antibodies to Oxidized LDL in Relation to Intima-Media Thickness in Carotid and Femoral Arteries in 58-Year-Old Subjectively Clinically Healthy Men Arterioscler. Thromb. Vasc. Biol., January 1, 2001; 21(1): 101 - 107. [Abstract] [Full Text] [PDF]

				C. Napoli, J. L. Witztum, F. Calara, F. de Nigris, and W. Palinski Maternal Hypercholesterolemia Enhances Atherogenesis in Normocholesterolemic Rabbits, Which Is Inhibited by Antioxidant or Lipid-Lowering Intervention During Pregnancy : An Experimental Model of Atherogenic Mechanisms in Human Fetuses Circ. Res., November 10, 2000; 87(10): 946 - 952. [Abstract] [Full Text] [PDF]

				E. A. Podrez, G. Hoppe, J. O'Neil, L. M. Sayre, N. Sheibani, and H. F. Hoff Macrophage receptors responsible for distinct recognition of low density lipoprotein containing pyrrole or pyridinium adducts: models of oxidized low density lipoprotein J. Lipid Res., September 1, 2000; 41(9): 1455 - 1463. [Abstract] [Full Text]

				F. G. de Oliveira, C. L. Rossi, M. G. de Oliveira, M. J.A. Saad, and L. A. Velloso Effect of vitamin E supplementation on antibody levels against malondialdehyde modified LDL in hyperlipidemic hamsters Cardiovasc Res, August 18, 2000; 47(3): 567 - 573. [Abstract] [Full Text] [PDF]

				K. L. Gillotte, S. Hörkkö, J. L. Witztum, and D. Steinberg Oxidized phospholipids, linked to apolipoprotein B of oxidized LDL, are ligands for macrophage scavenger receptors J. Lipid Res., May 1, 2000; 41(5): 824 - 833. [Abstract] [Full Text]

				G R. Hughes Immunology, lupus and atheroma Lupus, March 1, 2000; 9(3): 159 - 160. [PDF]

				O Vaarala Antibodies to oxidised LDL Lupus, March 1, 2000; 9(3): 202 - 205. [Abstract] [PDF]

				S. Tsimikas, B. P. Shortal, J. L. Witztum, and W. Palinski In Vivo Uptake of Radiolabeled MDA2, an Oxidation-Specific Monoclonal Antibody, Provides an Accurate Measure of Atherosclerotic Lesions Rich in Oxidized LDL and Is Highly Sensitive to Their Regression Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 689 - 697. [Abstract] [Full Text] [PDF]

				R. A. P. Skyrme-Jones, R. C. O'Brien, M. Luo, and I. T. Meredith Endothelial vasodilator function is related to low-density lipoprotein particle size and low-density lipoprotein vitamin E content in type 1 diabetes J. Am. Coll. Cardiol., February 1, 2000; 35(2): 292 - 299. [Abstract] [Full Text] [PDF]

				S. Parthasarathy, N. Santanam, S. Ramachandran, and O. Meilhac Oxidants and antioxidants in atherogenesis: an appraisal J. Lipid Res., December 1, 1999; 40(12): 2143 - 2157. [Abstract] [Full Text] [PDF]

				T. Hakkinen, J. S. Luoma, M. O. Hiltunen, C. H. Macphee, K. J. Milliner, L. Patel, S. Q. Rice, D. G. Tew, K. Karkola, and S. Yla-Herttuala Lipoprotein-Associated Phospholipase A2, Platelet-Activating Factor Acetylhydrolase, Is Expressed by Macrophages in Human and Rabbit Atherosclerotic Lesions Arterioscler. Thromb. Vasc. Biol., December 1, 1999; 19(12): 2909 - 2917. [Abstract] [Full Text] [PDF]

				W. Dichtl, A. Stiko, P. Eriksson, I. Goncalves, F. Calara, C. Banfi, M. P. S. Ares, A. Hamsten, and J. Nilsson Oxidized LDL and Lysophosphatidylcholine Stimulate Plasminogen Activator Inhibitor-1 Expression in Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., December 1, 1999; 19(12): 3025 - 3032. [Abstract] [Full Text] [PDF]

				E. Ahmed, J. Trifunovic, B. Stegmayr, G. Hallmans, and A. K. Lefvert Autoantibodies Against Oxidatively Modified LDL Do Not Constitute a Risk Factor for Stroke : A Nested Case-Control Study Stroke, December 1, 1999; 30(12): 2541 - 2546. [Abstract] [Full Text] [PDF]

				I. W. Fong, B. Chiu, E. Viira, D. Jang, and J. B. Mahony De Novo Induction of Atherosclerosis by Chlamydia pneumoniae in a Rabbit Model Infect. Immun., November 1, 1999; 67(11): 6048 - 6055. [Abstract] [Full Text] [PDF]

				C. Napoli, S. Salomone, T. Godfraind, W. Palinski, D. M. Capuzzi, G. Palumbo, F. P. D'Armiento, R. Donzelli, F. de Nigris, R. L. Capizzi, et al. 1,4-Dihydropyridine Calcium Channel Blockers Inhibit Plasma and LDL Oxidation and Formation of Oxidation-Specific Epitopes in the Arterial Wall and Prolong Survival in Stroke-Prone Spontaneously Hypertensive Rats • Editorial Comment Stroke, September 1, 1999; 30(9): 1907 - 1915. [Abstract] [Full Text] [PDF]

R. G. Salomon, W. Sha, C. Brame, K. Kaur, G. Subbanagounder, J. O'Neil, H. F. Hoff, and L. J. Roberts II Protein Adducts of Iso[4]levuglandin E2, a Product of the Isoprostane Pathway, in Oxidized Low Density Lipoprotein J. Biol. Chem., July 16, 1999; 274(29): 20271 - 20280. [Abstract] [Full Tex